Passa al contenuto
Merck

Colesevelam in the management of type 2 diabetes.

JPMA. The Journal of the Pakistan Medical Association (2020-05-14)
Sanjay Kalra, Gagan Priya, Sameer Aggarwal
ABSTRACT

Colesevelam is a bile acid sequestrant, approved for the management of both dyslipidaemia and type 2 diabetes. This review discusses the potential for the use of colesevelam in the management of type 2 diabetes. Expert opinion suggests possible indications where colesevelam may add value as a glucose lowering agent. It also highlights the limitations of the drug, and precautions that must be observed while using it.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Colesevelam hydrochloride, ≥98% (HPLC)